Acute pancreatitis associated with the use of peginterferon [5]

Pancreas

Volumn 34, Issue 4, 2007, Pages 485-487

  Ozdogan, Osman ^a   Tahan, Veysel ^a   Cincin, Altug ^a   Imeryuz, Nese ^a   Tozun, Nurdan ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ACUTE PANCREATITIS; ADVERSE OUTCOME; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANAMNESIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMEGALY; HUMAN; LABORATORY TEST; LETTER; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIDE EFFECT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ACUTE DISEASE; AGED; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; PANCREATITIS; RIBAVIRIN;

EID: 34248162025     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3180333afb     Document Type: Letter

References (10)

1. Eland IA, Rasch MC, Sturkenboom MJ, et al. Acute pancreatitis attributed to the use of interferon alfa-2b. Gastroenterology. 2000;119:230-233.
2. Cecchi E, Forte P, Cini E, et al. Pancreatitis induced by pegylated interferon alfa-2b in a patient affected by chronic hepatitis C. Emerg Med Australas. 2004;16:473-475.
3. Chaudhari S, Park J, Anand BS, et al. Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. Dig Dis Sci. 2004;49:1000-1006.
4. Soylu AR, Dokmeci G, Tezel A, et al. Lamivudine-induced acute pancreatitis in a patient with decompensated HBV-related chronic liver disease. J Clin Gastroenterol. 2004;38:134.
5. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39:709-716.
6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
7. Yousaf M, McCallion K, Diamond T. Management of severe acute pancreatitis. Br J Surg. 2003;90:407-420.
8. Mallory A, Kern F Jr. Drug-induced pancreatitis: a critical review. Gastroenterology. 1980;78:813-820.
9. Shinohara E, Yamashita S, Kihara S, et al. Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C. Hepatology. 1997;25:1502-1506.
10. Yamagishi S, Abe T, Sawada T. Human recombinant interferon alpha-2a (r IFN alpha-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient. Am J Gastroenterol. 1994;89:2280.